Generating and expanding autologous chimeric antigen receptor T cells from patients with acute myeloid leukemia

Saad Kenderian, Carl H. June, Saar Gill

Research output: Chapter in Book/Report/Conference proceedingChapter

3 Citations (Scopus)

Abstract

Adoptive transfer of genetically engineered T cells can lead to profound and durable responses in patients with hematologic malignancies, generating enormous enthusiasm among scientists, clinicians, patients, and biotechnology companies. The success of adoptive cellular immunotherapy depends upon the ability to manufacture good quality T cells. We discuss here the methodologies and reagents that are used to generate T cells for the preclinical study of chimeric antigen receptor T cell therapy for acute myeloid leukemia (AML).

Original languageEnglish (US)
Title of host publicationMethods in Molecular Biology
PublisherHumana Press Inc.
Pages267-276
Number of pages10
DOIs
StatePublished - Jan 1 2017

Publication series

NameMethods in Molecular Biology
Volume1633
ISSN (Print)1064-3745

Fingerprint

Antigen Receptors
Autoantigens
Acute Myeloid Leukemia
T-Lymphocytes
Adoptive Immunotherapy
Adoptive Transfer
Hematologic Neoplasms
Biotechnology
Cell- and Tissue-Based Therapy

Keywords

  • Acute myeloid leukemia
  • Adoptive T cell therapy
  • CAR T cells
  • Chimeric antigen receptor
  • Synthetic biology
  • T cell expansion

ASJC Scopus subject areas

  • Molecular Biology
  • Genetics

Cite this

Kenderian, S., June, C. H., & Gill, S. (2017). Generating and expanding autologous chimeric antigen receptor T cells from patients with acute myeloid leukemia. In Methods in Molecular Biology (pp. 267-276). (Methods in Molecular Biology; Vol. 1633). Humana Press Inc.. https://doi.org/10.1007/978-1-4939-7142-8_17

Generating and expanding autologous chimeric antigen receptor T cells from patients with acute myeloid leukemia. / Kenderian, Saad; June, Carl H.; Gill, Saar.

Methods in Molecular Biology. Humana Press Inc., 2017. p. 267-276 (Methods in Molecular Biology; Vol. 1633).

Research output: Chapter in Book/Report/Conference proceedingChapter

Kenderian, S, June, CH & Gill, S 2017, Generating and expanding autologous chimeric antigen receptor T cells from patients with acute myeloid leukemia. in Methods in Molecular Biology. Methods in Molecular Biology, vol. 1633, Humana Press Inc., pp. 267-276. https://doi.org/10.1007/978-1-4939-7142-8_17
Kenderian S, June CH, Gill S. Generating and expanding autologous chimeric antigen receptor T cells from patients with acute myeloid leukemia. In Methods in Molecular Biology. Humana Press Inc. 2017. p. 267-276. (Methods in Molecular Biology). https://doi.org/10.1007/978-1-4939-7142-8_17
Kenderian, Saad ; June, Carl H. ; Gill, Saar. / Generating and expanding autologous chimeric antigen receptor T cells from patients with acute myeloid leukemia. Methods in Molecular Biology. Humana Press Inc., 2017. pp. 267-276 (Methods in Molecular Biology).
@inbook{ddc509f0cd41426994d14227141e016b,
title = "Generating and expanding autologous chimeric antigen receptor T cells from patients with acute myeloid leukemia",
abstract = "Adoptive transfer of genetically engineered T cells can lead to profound and durable responses in patients with hematologic malignancies, generating enormous enthusiasm among scientists, clinicians, patients, and biotechnology companies. The success of adoptive cellular immunotherapy depends upon the ability to manufacture good quality T cells. We discuss here the methodologies and reagents that are used to generate T cells for the preclinical study of chimeric antigen receptor T cell therapy for acute myeloid leukemia (AML).",
keywords = "Acute myeloid leukemia, Adoptive T cell therapy, CAR T cells, Chimeric antigen receptor, Synthetic biology, T cell expansion",
author = "Saad Kenderian and June, {Carl H.} and Saar Gill",
year = "2017",
month = "1",
day = "1",
doi = "10.1007/978-1-4939-7142-8_17",
language = "English (US)",
series = "Methods in Molecular Biology",
publisher = "Humana Press Inc.",
pages = "267--276",
booktitle = "Methods in Molecular Biology",

}

TY - CHAP

T1 - Generating and expanding autologous chimeric antigen receptor T cells from patients with acute myeloid leukemia

AU - Kenderian, Saad

AU - June, Carl H.

AU - Gill, Saar

PY - 2017/1/1

Y1 - 2017/1/1

N2 - Adoptive transfer of genetically engineered T cells can lead to profound and durable responses in patients with hematologic malignancies, generating enormous enthusiasm among scientists, clinicians, patients, and biotechnology companies. The success of adoptive cellular immunotherapy depends upon the ability to manufacture good quality T cells. We discuss here the methodologies and reagents that are used to generate T cells for the preclinical study of chimeric antigen receptor T cell therapy for acute myeloid leukemia (AML).

AB - Adoptive transfer of genetically engineered T cells can lead to profound and durable responses in patients with hematologic malignancies, generating enormous enthusiasm among scientists, clinicians, patients, and biotechnology companies. The success of adoptive cellular immunotherapy depends upon the ability to manufacture good quality T cells. We discuss here the methodologies and reagents that are used to generate T cells for the preclinical study of chimeric antigen receptor T cell therapy for acute myeloid leukemia (AML).

KW - Acute myeloid leukemia

KW - Adoptive T cell therapy

KW - CAR T cells

KW - Chimeric antigen receptor

KW - Synthetic biology

KW - T cell expansion

UR - http://www.scopus.com/inward/record.url?scp=85029364519&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85029364519&partnerID=8YFLogxK

U2 - 10.1007/978-1-4939-7142-8_17

DO - 10.1007/978-1-4939-7142-8_17

M3 - Chapter

C2 - 28735493

AN - SCOPUS:85029364519

T3 - Methods in Molecular Biology

SP - 267

EP - 276

BT - Methods in Molecular Biology

PB - Humana Press Inc.

ER -